mHealth Intervention for Improving Vaccination Coverage in Bangladesh
Mobile Health Solutions Combined With Behavior Change Approaches to Improve Vaccination Coverage and Timeliness in Bangladesh: a Cluster Randomized Controlled Trial
1 other identifier
interventional
7,800
0 countries
N/A
Brief Summary
Noncompliance and delay in vaccination have caused millions of preventable deaths worldwide particularly in low-and middle-income countries (LMICs). The main reasons for delay in vaccinations or dropout from vaccination programs are vaccine hesitancy, lack of knowledge, forgetting due date, lack of trust, and religious and social barriers. Recently, various mobile health (mHealth) interventions such as voice call, text message reminders have been implemented in LMICs to improve awareness of vaccine availability and provide timely reminders. However, the implication and impact assessment of mHealth interventions with behavior change message for improving vaccination coverage and timeliness is limited. In this project, a three-armed cluster randomized controlled trial (cRCT) will be conducted to assess the impact and cost-effectiveness of mHealth interventions with behavioral change approach on vaccination coverage and timeliness in Bangladesh. A total of 7800 caregivers of children aged less than 4 weeks will be recruited and randomly allocated equally to each arm: control, voice call, and short message service (SMS) reminders with behavioral change message. The primary outcomes will include coverage of full immunization among children in first year of life, and secondary outcomes will be coverage for each vaccine, timeliness, and infant mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2026
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 29, 2026
CompletedFirst Posted
Study publicly available on registry
April 6, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
Study Completion
Last participant's last visit for all outcomes
December 31, 2028
April 14, 2026
April 1, 2026
4 months
March 29, 2026
April 9, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Full vaccination
Full vaccination coverage by 12 months of age is defined as receiving all scheduled vaccines (BCG, 3 doses of DPT, 3 doses of polio, and 1 dose of MCV1).
1 year
Vaccine Timeliness
Timeliness of vaccination: measured by whether each vaccine was administered within 2 weeks of the recommended schedule (at ages 6 weeks, 10 weeks, 14 weeks, and 9 months)
1 year
Secondary Outcomes (2)
Vaccination coverage
1 year
Cost-effectiveness of the intervention
1 year after
Study Arms (3)
Automatic voice call
EXPERIMENTALAn automatic voice call will be sent on 3 days and one day before the scheduled visit at 6 weeks, 10 weeks, and 14 weeks for the three doses of DPT vaccine and age 9 months for MCV1 vaccine.
Text with behavior change messages
EXPERIMENTALThe study participant will receive the text message 3 and 1 days before the vaccination schedule
Control
ACTIVE COMPARATORThe participant of the control group will receive only standard care.
Interventions
An automatic voice call with behavior change messages will be sent on 3 days and one day before the scheduled visit at 6 weeks, 10 weeks, and 14 weeks for the three doses of DPT vaccine and age 9 months for MCV1 vaccine. The reminder will be sent in local language.
SMS will be sent on 3 days and one day before the scheduled visit at 6 weeks, 10 weeks, and 14 weeks for the three doses of DPT vaccine and age 9 months for MCV1 vaccine.
Eligibility Criteria
You may qualify if:
- You are the infant's caregiver (mother, father, or legal guardian).
- The infant is less than 4 weeks (28 days) old at the time of enrollment.
- You reside within the jurisdiction of the designated community health center and have no plans to move within the next 12 months.
- Depending on your assigned group, you can do one of the following:
- You can read Bengali SMS messages yourself.
- You can receive support from a family member living with you who reads Bengali aloud.
- (Note: For the voice call group, literacy is not an issue.)
- You understand the content of this study and have completed the required informed consent form.
You may not qualify if:
- Caregivers of children aged 4 weeks or older at the time of enrollment
- Children who have received any vaccine other than BCG or polio at birth
- The caregiver plans to move out of the study area within the next six months.
- The caregiver does not want to receive the vaccination at the intervention health center.
- The caregiver (father, mother, or other family member) does not have a phone.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 29, 2026
First Posted
April 6, 2026
Study Start (Estimated)
May 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 31, 2028
Last Updated
April 14, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share